Actinium Pharmaceuticals
ATNM
ATNM
31 hedge funds and large institutions have $8.16M invested in Actinium Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.35% more ownership
Funds ownership: 0.24% → 0.59% (+0.35%)
Holders
31
Holding in Top 10
–
Calls
$39K
Puts
–
Top Buyers
| 1 | +$2.52M | |
| 2 | +$1.4M | |
| 3 | +$915K | |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$589K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$431K |
Top Sellers
| 1 | -$86.2K | |
| 2 | -$45K | |
| 3 | -$22K | |
| 4 |
Renaissance Technologies
New York
|
-$14K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$5K |